<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="iso-abbrev">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="publisher-id">nar</journal-id>
    <journal-title-group>
      <journal-title>Nucleic Acids Research</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">0305-1048</issn>
    <issn pub-type="epub">1362-4962</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">9825543</article-id>
    <article-id pub-id-type="pmid">36399497</article-id>
    <article-id pub-id-type="doi">10.1093/nar/gkac1056</article-id>
    <article-id pub-id-type="publisher-id">gkac1056</article-id>
    <article-categories>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI00010</subject>
      </subj-group>
      <subj-group subj-group-type="heading">
        <subject>Database Issue</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>IntroVerse: a comprehensive database of introns across human tissues</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>García-Ruiz</surname>
          <given-names>Sonia</given-names>
        </name>
        <aff><institution>Department of Genetics and Genomic Medicine Research &amp; Teaching, UCL GOS Institute of Child Health</institution>, <addr-line>London</addr-line>, WC1N 1EH, <country country="GB">UK</country></aff>
        <aff><institution>Department of Neurodegenerative Disease, Queen Square Institute of Neurology</institution>, UCL, <addr-line>London</addr-line> WC1N 3BG, <country country="GB">UK</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0541-7537</contrib-id>
        <name>
          <surname>Gustavsson</surname>
          <given-names>Emil K</given-names>
        </name>
        <aff><institution>Department of Genetics and Genomic Medicine Research &amp; Teaching, UCL GOS Institute of Child Health</institution>, <addr-line>London</addr-line>, WC1N 1EH, <country country="GB">UK</country></aff>
        <aff><institution>Department of Neurodegenerative Disease, Queen Square Institute of Neurology</institution>, UCL, <addr-line>London</addr-line> WC1N 3BG, <country country="GB">UK</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-2382-8460</contrib-id>
        <name>
          <surname>Zhang</surname>
          <given-names>David</given-names>
        </name>
        <aff><institution>Department of Genetics and Genomic Medicine Research &amp; Teaching, UCL GOS Institute of Child Health</institution>, <addr-line>London</addr-line>, WC1N 1EH, <country country="GB">UK</country></aff>
        <aff><institution>Department of Neurodegenerative Disease, Queen Square Institute of Neurology</institution>, UCL, <addr-line>London</addr-line> WC1N 3BG, <country country="GB">UK</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Reynolds</surname>
          <given-names>Regina H</given-names>
        </name>
        <aff><institution>Department of Genetics and Genomic Medicine Research &amp; Teaching, UCL GOS Institute of Child Health</institution>, <addr-line>London</addr-line>, WC1N 1EH, <country country="GB">UK</country></aff>
        <aff><institution>Department of Neurodegenerative Disease, Queen Square Institute of Neurology</institution>, UCL, <addr-line>London</addr-line> WC1N 3BG, <country country="GB">UK</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Chen</surname>
          <given-names>Zhongbo</given-names>
        </name>
        <aff><institution>Department of Genetics and Genomic Medicine Research &amp; Teaching, UCL GOS Institute of Child Health</institution>, <addr-line>London</addr-line>, WC1N 1EH, <country country="GB">UK</country></aff>
        <aff><institution>Department of Neurodegenerative Disease, Queen Square Institute of Neurology</institution>, UCL, <addr-line>London</addr-line> WC1N 3BG, <country country="GB">UK</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Fairbrother-Browne</surname>
          <given-names>Aine</given-names>
        </name>
        <aff><institution>Department of Genetics and Genomic Medicine Research &amp; Teaching, UCL GOS Institute of Child Health</institution>, <addr-line>London</addr-line>, WC1N 1EH, <country country="GB">UK</country></aff>
        <aff><institution>Department of Neurodegenerative Disease, Queen Square Institute of Neurology</institution>, UCL, <addr-line>London</addr-line> WC1N 3BG, <country country="GB">UK</country></aff>
        <aff><institution>Department of Medical and Molecular Genetics, School of Basic and Medical Biosciences, King's College London</institution>, <addr-line>London</addr-line>, WC2R 2LS, <country country="GB">UK</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Gil-Martínez</surname>
          <given-names>Ana Luisa</given-names>
        </name>
        <aff><institution>Department of Neurodegenerative Disease, Queen Square Institute of Neurology</institution>, UCL, <addr-line>London</addr-line> WC1N 3BG, <country country="GB">UK</country></aff>
        <aff><institution>Department of Information and Communications Engineering Faculty of Informatics, Espinardo Campus, University of Murcia</institution>, <addr-line>Murcia</addr-line>, 30100, <country country="ES">Spain</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Botia</surname>
          <given-names>Juan A</given-names>
        </name>
        <aff><institution>Department of Information and Communications Engineering Faculty of Informatics, Espinardo Campus, University of Murcia</institution>, <addr-line>Murcia</addr-line>, 30100, <country country="ES">Spain</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Collado-Torres</surname>
          <given-names>Leonardo</given-names>
        </name>
        <aff><institution>Lieber Institute for Brain Development</institution>, <addr-line>Baltimore</addr-line>, MD 21205, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-9520-6957</contrib-id>
        <name>
          <surname>Ryten</surname>
          <given-names>Mina</given-names>
        </name>
        <!--mina.ryten@ucl.ac.uk-->
        <aff><institution>Department of Genetics and Genomic Medicine Research &amp; Teaching, UCL GOS Institute of Child Health</institution>, <addr-line>London</addr-line>, WC1N 1EH, <country country="GB">UK</country></aff>
        <aff><institution>Department of Neurodegenerative Disease, Queen Square Institute of Neurology</institution>, UCL, <addr-line>London</addr-line> WC1N 3BG, <country country="GB">UK</country></aff>
        <aff><institution>NIHR Great Ormond Street Hospital Biomedical Research Centre, University College London</institution>, <addr-line>London</addr-line>, WC1N 1EH, <country country="GB">UK</country></aff>
        <xref rid="COR1" ref-type="corresp"/>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="COR1">To whom correspondence should be addressed. Tel: +44 2081387617; Email: <email>mina.ryten@ucl.ac.uk</email></corresp>
    </author-notes>
    <pub-date pub-type="collection">
      <day>06</day>
      <month>1</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2022-11-18">
      <day>18</day>
      <month>11</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>18</day>
      <month>11</month>
      <year>2022</year>
    </pub-date>
    <volume>51</volume>
    <issue>D1</issue>
    <fpage>D167</fpage>
    <lpage>D178</lpage>
    <history>
      <date date-type="accepted">
        <day>30</day>
        <month>10</month>
        <year>2022</year>
      </date>
      <date date-type="rev-recd">
        <day>21</day>
        <month>10</month>
        <year>2022</year>
      </date>
      <date date-type="received">
        <day>15</day>
        <month>8</month>
        <year>2022</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2022. Published by Oxford University Press on behalf of Nucleic Acids Research.</copyright-statement>
      <copyright-year>2023</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="gkac1056.pdf"/>
    <abstract>
      <title>Abstract</title>
      <p>Dysregulation of RNA splicing contributes to both rare and complex diseases. RNA-sequencing data from human tissues has shown that this process can be inaccurate, resulting in the presence of novel introns detected at low frequency across samples and within an individual. To enable the full spectrum of intron use to be explored, we have developed IntroVerse, which offers an extensive catalogue on the splicing of 332,571 annotated introns and a linked set of 4,679,474 novel junctions covering 32,669 different genes. This dataset has been generated through the analysis of 17,510 human control RNA samples from 54 tissues provided by the Genotype-Tissue Expression Consortium. IntroVerse has two unique features: (i) it provides a complete catalogue of novel junctions and (ii) each novel junction has been assigned to a specific annotated intron. This unique, hierarchical structure offers multiple uses, including the identification of novel transcripts from known genes and their tissue-specific usage, and the assessment of background splicing noise for introns thought to be mis-spliced in disease states. IntroVerse provides a user-friendly web interface and is freely available at <ext-link xlink:href="https://rytenlab.com/browser/app/introverse" ext-link-type="uri">https://rytenlab.com/browser/app/introverse</ext-link>.</p>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>AWS Web Services</institution>
          </institution-wrap>
        </funding-source>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Tenure Track Clinician Scientist Fellowship</institution>
          </institution-wrap>
        </funding-source>
        <award-id>MR/N008324/1</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>BrightFocus Foundation</institution>
            <institution-id institution-id-type="DOI">10.13039/100006312</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>A2021009F</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Leonard Wolfson Foundation</institution>
          </institution-wrap>
        </funding-source>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Biotechnology and Biological Sciences Research Council</institution>
            <institution-id institution-id-type="DOI">10.13039/501100000268</institution-id>
          </institution-wrap>
        </funding-source>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Fundación Séneca</institution>
            <institution-id institution-id-type="DOI">10.13039/100007801</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>21230/PD/19</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Science and Technology Agency, Séneca Foundation</institution>
          </institution-wrap>
        </funding-source>
        <award-id>00007/COVI/20</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>National Institutes of Health</institution>
            <institution-id institution-id-type="DOI">10.13039/100000002</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>R01MH123567</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="12"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec sec-type="intro" id="SEC1">
    <title>INTRODUCTION</title>
    <p>Since the discovery of introns in 1977 (<xref rid="B1" ref-type="bibr">1</xref>,<xref rid="B2" ref-type="bibr">2</xref>), there has been increasing interest in splicing and, in particular, in alternative splicing as a means of generating transcriptomic diversity. In humans, it is now recognised that nearly all multi-exon genes have multiple isoforms (<xref rid="B3" ref-type="bibr">3</xref>,<xref rid="B4" ref-type="bibr">4</xref>) and that dysregulation of splicing contributes to both rare and complex disease (<xref rid="B5" ref-type="bibr">5–7</xref>). Many of these insights have been gained using short-read RNA-sequencing data (<xref rid="B8" ref-type="bibr">8</xref>), which enables high throughput novel intron discovery by identifying reads which map with a gapped alignment to the genome, termed junction reads. To date, most RNA-sequencing splicing analyses have focused on identifying functionally important transcripts, their exons and usage, with an increasing interest in disease-specific applications as exemplified by RJunBase (<xref rid="B9" ref-type="bibr">9</xref>) (that offers an extended classification of splice junctions from non-cancerous and cancerous human samples). These priorities are reflected in existing splicing databases, which commonly filter splicing events based on their frequency, such that only a subset of introns thought to be part of stable transcripts are visible to the user (<xref rid="B10" ref-type="bibr">10–13</xref>) or do not provide a freely-available user-friendly web tool to browse and explore all detected novel junctions and their implied introns (<xref rid="B14" ref-type="bibr">14</xref>,<xref rid="B15" ref-type="bibr">15</xref>).</p>
    <p>However, the increasing depth and availability of large quantities of publicly accessible RNA-sequencing data have made clear that splicing errors are common (<xref rid="B16" ref-type="bibr">16–19</xref>), resulting in the consistent detection of partially-unannotated junction reads at low frequency across samples and within individuals (<xref rid="B19" ref-type="bibr">19</xref>). Quantifying these errors, differentiating them from splicing events due to the presence of novel rare transcripts and identifying patterns in splicing variation have become increasingly important with the recognition of the role of splicing in ageing (DOI:10.1101/2022.03.14.484341), the use of RNA-sequencing data to improve diagnostics (<xref rid="B20" ref-type="bibr">20</xref>) and the use of long-read RNA-sequencing data for discovery of rare transcripts (<xref rid="B21" ref-type="bibr">21</xref>). Despite this interest, there are no existing databases that allow the full spectrum of intron use to be explored.</p>
    <p>To bridge this gap, we created IntroVerse, which currently offers an extensive catalogue on the usage of 332,571 annotated introns and a linked set of 4,679,474 novel junctions and their implied novel introns covering 32,669 different genes. This data set was generated through the analysis of 17,510 human control RNA samples across 54 tissues provided by the Genotype-Tissue Expression Consortium v8 (<xref rid="B22" ref-type="bibr">22</xref>) and processed by recount3 (<xref rid="B23" ref-type="bibr">23</xref>). IntroVerse has two unique features: (i) it provides a complete catalogue of carefully processed and quality-controlled annotated introns and (ii) each novel junction (as implied by a novel split read) has been assigned to a specific annotated intron. The latter is key to the creation of a hierarchical database structure which allows the user to start by browsing a gene or genomic position of interest and end with an exploration of the entire catalogue of alternative splicing events. To enable users to prioritise annotated introns and novel junctions of greatest interest, we also provide complementary information on key parameters including: measures of splicing accuracy at each annotated intron, the percentage of individuals in which each splicing event has been observed, 5’ and 3’ sequence strength (<xref rid="B24" ref-type="bibr">24</xref>), sequence conservation (<xref rid="B25" ref-type="bibr">25</xref>) across primates in proximal intronic regions, sequence constraint (<xref rid="B26" ref-type="bibr">26</xref>) across humans in proximal intronic regions and mean read coverage. Furthermore, IntroVerse offers the user the opportunity to visualise novel junctions and their frequency within the main transcript structure, with the resulting plots downloadable in SVG format.</p>
    <p>IntroVerse has common use cases relevant to a range of user groups which include: (i) the assessment of background splicing noise for introns thought to be mis-spliced in disease states so aiding diagnosis of rare pathogenic splicing mutations and (ii) the identification of novel transcripts of known genes and their tissue-specific usage. Focusing on the latter, we note that in a single tissue, frontal cortex, we detected 2,048 novel junctions which are used in &gt; 80% of independent samples (<italic toggle="yes">N</italic> = 167) and which correspond to 1,420 genes suggesting the existence of incomplete annotation at these sites. Importantly, we found that the discovery of such sites was only weakly correlated with read coverage (<italic toggle="yes">R</italic><sup>2</sup> = 3.7e-2, <italic toggle="yes">P-</italic>value &lt; 2e−16, <xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S1</xref>). Thus, IntroVerse enables the efficient identification of genes for which existing transcriptome annotation is incomplete, providing key information to direct targeted analyses.</p>
    <p>IntroVerse does not require registration or login for access, and it is freely available for research use and data download from multiple devices, screen sizes and browsers at <ext-link xlink:href="https://rytenlab.com/browser/app/introverse" ext-link-type="uri">https://rytenlab.com/browser/app/introverse</ext-link>. IntroVerse is also available in docker format at <ext-link xlink:href="https://hub.docker.com/r/soniaruiz/introverse" ext-link-type="uri">https://hub.docker.com/r/soniaruiz/introverse</ext-link>.</p>
  </sec>
  <sec sec-type="materials|methods" id="SEC2">
    <title>MATERIALS AND METHODS</title>
    <sec id="SEC2-1">
      <title>GTEx v8 data collection and processing of split read data</title>
      <p>IntroVerse is based on RNA-sequencing data generated by the GTEx v8 (<xref rid="B22" ref-type="bibr">22</xref>) project. As such it includes data on 17,510 samples across 948 post-mortem donors and 54 tissues after accounting for the exclusion of samples that did not meet the minimum GTEx quality control criteria <monospace>(gtex.smafrze = ‘EXCLUDE’; <italic toggle="yes">N</italic> = 1,571</monospace>) (Figure <xref rid="F1" ref-type="fig">1</xref>, Figure <xref rid="F2" ref-type="fig">2</xref>). RNA-sequencing data from the project, which used the Illumina TruSeq library construction protocol (non-stranded 75 base pairs (bp) long reads, polyA+ selection), was processed by recount3 using Monorail (<xref rid="B23" ref-type="bibr">23</xref>). The latter implements STAR (<xref rid="B27" ref-type="bibr">27</xref>) to align reads to the human genome (hg38/GRCh38) and summarise split reads (those mapping to the genome with a gapped alignment), and Megadepth (<xref rid="B28" ref-type="bibr">28</xref>) version 1.0.3 to analyse the BAM file outputs generated by STAR. We downloaded all split read data corresponding to GTEx v8 samples using the R package <monospace>recount3</monospace> version 1.6.0.</p>
      <fig position="float" id="F1">
        <label>Figure 1.</label>
        <caption>
          <p>Overview of the quality-control steps applied to the original dataset of split reads provided by GTEx v8 and processed by recount3. (<bold>A</bold>) Length of the canonical splicing signals. All split reads considered were at least 25 bp long. (<bold>B</bold>) Length of the proximal intronic regions that were considered for the calculation of the mean conservation score across primates and mean constraint values across humans of the overlapping sequences. (<bold>C</bold>) Flow chart containing the complete quality-control process applied to the original dataset of split reads provided by GTEx v8 and processed by recount3 before the construction of IntroVerse.</p>
        </caption>
        <graphic xlink:href="gkac1056fig1" position="float"/>
      </fig>
      <fig position="float" id="F2">
        <label>Figure 2.</label>
        <caption>
          <p>Data statistics and SQL Schema designed for IntroVerse. (<bold>A</bold>) Sample count by tissue. Each bar represents the number of samples per body site considered in IntroVerse. (<bold>B</bold>) Database summary statistics. (<bold>C</bold>) SQL schema design for IntroVerse. The table <italic toggle="yes">‘annotated intron’</italic> corresponds to the table <italic toggle="yes">‘intron’</italic> in the SQLite schema, and the table <italic toggle="yes">‘novel junction’</italic> refers to the table <italic toggle="yes">‘novel’</italic> in the SQLite schema.</p>
        </caption>
        <graphic xlink:href="gkac1056fig2" position="float"/>
      </fig>
      <p>To identify split reads that were most likely to be generated through the activity of spliceosomes, we removed all reads whose implied intron length (defined by the gap in alignment to the genome) was less than 25 bp, the minimum length required for all essential splicing signals (<xref rid="B29" ref-type="bibr">29</xref>) (Figure <xref rid="F1" ref-type="fig">1</xref>). In order to increase the confidence in the spliceosome origin of these split reads, we discarded the reads located within unlocalized and unplaced (i.e. random) sequences, due to their inability to be located within the hg38 chromosomes 1–22 (chr1–chr22), X (chrX), Y (chrY) with a specific order and orientation. We also discarded all split reads that overlapped with any regions published within the ENCODE Blacklist (<xref rid="B30" ref-type="bibr">30</xref>) (Figure <xref rid="F1" ref-type="fig">1</xref>) as this list contains the DNA regions (hg38) where assembly had been difficult and, thus, their removal result in an essential quality measure.</p>
      <p>The split reads meeting these initial quality-control criteria were then annotated to the Ensembl v105 reference transcriptome by using the <monospace>junction_annot()</monospace> function made available through the Bioconductor R package <monospace>dasper</monospace> (DOI:10.1101/2021.03.29.437534) version 1.4.3. Depending on the genomic coordinates of the split reads, these were classified by <monospace>dasper</monospace> into seven different junction categories: annotated, novel donor, novel acceptor, novel combo, novel exon skip, ambiguous and completely unannotated. Due to their unique ability to be linked to an annotated intron and, therefore, to a gene in annotation, we only considered reads classified as (i) <italic toggle="yes">‘annotated’</italic> junction reads, defined as split reads for which both ends of the implied intron precisely matched an intron within annotation, (ii) <italic toggle="yes">‘novel donor’</italic> junction reads, defined as split reads for which only the acceptor site precisely matched an intron-exon boundary within annotation and (iii) <italic toggle="yes">‘novel acceptor’</italic> junction reads, defined as split reads for which only the donor site precisely matched an exon-intron boundary within the annotation (Figure <xref rid="F1" ref-type="fig">1C</xref>). These three types of split read, henceforth referred to as annotated introns, novel donor and novel acceptor junctions, were incorporated into IntroVerse. The latter two categories, collectively referred to as novel junctions, implied the usage of novel introns.</p>
    </sec>
    <sec id="SEC2-2">
      <title>Identification of mis-splicing events and their association to annotated introns</title>
      <p>By default, novel junctions meeting the criteria defined in <italic toggle="yes">GTEx v8 data collection and processing of</italic><italic toggle="yes">split read data</italic>, were considered to be products of mis-splicing events generated through the inaccurate excision of annotated introns (defined by Ensembl v105). While this definition of mis-splicing assumes that current transcriptome annotation is complete (which we recognise is not the case), it is important to note that the addition of novel introns into annotation has been plateauing for some time (<xref rid="B14" ref-type="bibr">14</xref>) making this a reasonable working assumption.</p>
      <p>Next, to enable the identification of mis-splicing events, we started by assigning each novel donor and acceptor junction to a known annotated intron through sharing of their single annotated splice site (Figure <xref rid="F3" ref-type="fig">3B</xref>). To increase confidence in junction pairing, we ensured that each novel junction was only paired to an annotated intron if there was also evidence for use of that specific annotated intron in every sample in which the novel junction was found, as defined by the presence of ≥ 1 annotated junction read in each sample. In total, 730,125 novel donor and acceptor junctions were discarded from this project as there was not any compatible annotated intron meeting the aforementioned criteria to pair them with among the set of samples studied.</p>
      <fig position="float" id="F3">
        <label>Figure 3.</label>
        <caption>
          <p>Overall design and construction of IntroVerse. (<bold>A</bold>) Summary of data collection and processing. (<bold>B</bold>) Summary of the process used for annotated intron and novel junction pairing. ‘AnnotatedSS’ refers to annotated splice site and ‘novelSS’ refers to novel splice site. (<bold>C</bold>) Summary of the cardinality between the annotated introns and novel junctions in IntroVerse. (<bold>D</bold>) Visualisation of a novel junction and the mis-splicing activity occurring within the MANE transcript of a selected gene using ggtranscript (<xref rid="B35" ref-type="bibr">35</xref>).</p>
        </caption>
        <graphic xlink:href="gkac1056fig3" position="float"/>
      </fig>
      <p>Since we considered mis-splicing to be the result of the inaccurate excision of annotated introns, a novel junction could only be the result of the mis-splicing of a single unique intron, regardless of the sample or body site in which the novel event had been found. Consequently, all novel donor and acceptor junctions able to be paired to multiple annotated introns within a sample or across samples, were considered ambiguous and discarded from this project. This resulted in the discard of 346,419 ambiguous novel junctions and 17,906 annotated introns that were uniquely parenting them, with none of them included in IntroVerse. In total, 1,094,450 annotated introns and novel junctions were excluded from IntroVerse (Figure <xref rid="F1" ref-type="fig">1</xref>).</p>
    </sec>
    <sec id="SEC2-3">
      <title>Quantifying the levels of mis-splicing at an annotated intron using the mis-splicing ratio measure</title>
      <p>To determine the mis-splicing rate for any annotated intron across samples of a given tissue, we generated a measure, which we termed the mis-splicing ratio (<inline-formula><tex-math id="M0001" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$MSR$\end{document}</tex-math></inline-formula>). Two <inline-formula><tex-math id="M0001a" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$MSR$\end{document}</tex-math></inline-formula> values were calculated for each annotated intron to provide a measure of the frequency of mis-splicing at the donor (<inline-formula><tex-math id="M0002" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$MS{R_D}$\end{document}</tex-math></inline-formula>) and acceptor splice sites (<inline-formula><tex-math id="M0003" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$MS{R_A}$\end{document}</tex-math></inline-formula>) separately.</p>
      <p>The <inline-formula><tex-math id="M0004" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$MS{R_D}$\end{document}</tex-math></inline-formula> and <inline-formula><tex-math id="M0005" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$MS{R_A}$\end{document}</tex-math></inline-formula> measures for a given annotated intron were calculated by first summing together all novel donor and novel acceptor junction read counts respectively that were attached to the annotated intron across all samples of the tissue, and then dividing that value by the sum of all annotated intron and novel junction read counts across the same set of samples. Focusing on the <inline-formula><tex-math id="M0006" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$MS{R_D}$\end{document}</tex-math></inline-formula> measure, this can be formally described as below:<disp-formula><tex-math id="M0007" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$$\begin{equation*}MSR_D^X = \frac{{\mathop \sum \nolimits_{i = 1}^N {j_i}}}{{\mathop \sum \nolimits_{i = 1}^N {j_i} + \mathop \sum \nolimits_{i = 1}^N {s_i}}}\end{equation*}$$\end{document}</tex-math></disp-formula></p>
      <p>Let <inline-formula><tex-math id="M0008" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$j$\end{document}</tex-math></inline-formula> denote the total number of novel donor junction reads assigned to the annotated intron <inline-formula><tex-math id="M0009" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$X$\end{document}</tex-math></inline-formula> within one sample of our study set. Let <inline-formula><tex-math id="M00010" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$s$\end{document}</tex-math></inline-formula> denote the total number of annotated junction reads for the same intron, <inline-formula><tex-math id="M00011" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$X$\end{document}</tex-math></inline-formula>, within the same sample of our study set. Let <inline-formula><tex-math id="M00012" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$N$\end{document}</tex-math></inline-formula> denote the total number of samples studied within our study set.</p>
      <p>We then mirrored the formula above to produce the <inline-formula><tex-math id="M00013" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$MS{R_A}$\end{document}</tex-math></inline-formula> measure.</p>
      <p>Both <inline-formula><tex-math id="M00014" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$MS{R_D}$\end{document}</tex-math></inline-formula> and <inline-formula><tex-math id="M00015" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$MS{R_A}$\end{document}</tex-math></inline-formula> values were calculated per annotated intron across the samples of each tissue, and ranged between 0 and 1. Whereas 0 value represented accurate splicing at the donor or acceptor site of the annotated intron of interest as compared to the reference transcriptome Ensembl v105, 1 value represented complete mis-splicing of the splice site. This adaptation of the method for normalisation of library sizes (<xref rid="B31" ref-type="bibr">31</xref>) accounted for variability in expression and read depth across different genes and introns, enabling the comparison of mis-splicing activity across introns.</p>
      <p>It is important to note that both <inline-formula><tex-math id="M00016" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$MS{R_D}$\end{document}</tex-math></inline-formula> and <inline-formula><tex-math id="M00017" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$MS{R_A}$\end{document}</tex-math></inline-formula> scores were only calculated when there was evidence of the annotated intron being detected within the tissue as defined by the presence of ≥ 1 supporting split reads. Given that some transcripts are not expressed in all tissues, the corresponding annotated introns would not be detected, and so the <inline-formula><tex-math id="M00018" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$MS{R_D}$\end{document}</tex-math></inline-formula> and <inline-formula><tex-math id="M00019" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$MS{R_A}$\end{document}</tex-math></inline-formula> values were not calculated. In fact, the median number of annotated introns across tissues as stored on IntroVerse corresponds to 239,839 and ranges from 187,551 to 279,156 annotated introns (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S1</xref>).</p>
    </sec>
    <sec id="SEC2-4">
      <title>Database generation</title>
      <p>All annotated introns, and their related novel donor and acceptor junctions, were classified by tissue and stored within tables in a relational database that was named IntroVerse. To build this database, we used the <monospace>SQLite R</monospace> package version 2.2.7 (Figure <xref rid="F3" ref-type="fig">3C</xref>). All annotated introns in all tissues were stored within a master table called <italic toggle="yes">‘intron’</italic>, whereas all novel donor and novel acceptor junctions were stored together within another master table called <italic toggle="yes">‘novel’</italic>. These two master tables were related with a cardinality of 1:<italic toggle="yes">N</italic>, meaning that each annotated intron could be paired with multiple novel junctions, whereas each novel junction could only be paired with a single, unique annotated intron. An additional master table was created to store information about all genes from which the annotated introns originated. Two child tables were then generated per GTEx tissue and contained: (i) all novel junctions found across samples of each tissue and paired with an intron in annotation and (ii) all annotated introns that showed accurate splicing activity (defined by Ensembl v105) across the samples of the studied tissue (Figure <xref rid="F2" ref-type="fig">2C</xref>).</p>
      <p>Multiple intron- and gene-level features were incorporated as columns to the master tables of the IntroVerse database:</p>
      <list list-type="alpha-lower">
        <list-item>
          <p>
            <bold>Intron-level properties:</bold>
          </p>
          <list list-type="roman-lower">
            <list-item>
              <p>The intron length (in base pairs).</p>
            </list-item>
            <list-item>
              <p>The strength of the 5’ or 3’ splicing signals as generated by the MaxEntScan (<xref rid="B24" ref-type="bibr">24</xref>) score (MES) algorithm. This method uses probabilistic models of sequence motifs involved in RNA splicing and their adjacent positions to score the 9 bp sequence at the 5’ splice site and the 23 bp sequence at the 3’ splice site. The higher the maximum entropy score assigned to a given sequence, the more closely the sequence evaluated corresponds to an annotated splice site.</p>
            </list-item>
            <list-item>
              <p>The mean inter-species conservation (<xref rid="B25" ref-type="bibr">25</xref>) score across primates assigned to the 5’ and 3’ proximal exon-intron junction regions. The 5’ proximal region was defined as 5 bp upstream of the 5’ splice site to 35 bp into the downstream intron. The 3’ proximal region was defined as 35 bp upstream of the 3’ splice site to 5 bp into the downstream exon (Figure <xref rid="F1" ref-type="fig">1B</xref>). This score was calculated by obtaining the mean of the <italic toggle="yes">phastCons20</italic> scores (<ext-link xlink:href="http://hgdownload.cse.ucsc.edu/goldenPath/hg38/phastCons20way/" ext-link-type="uri">http://hgdownload.cse.ucsc.edu/goldenPath/hg38/phastCons20way/</ext-link>) assigned to each proximal intronic region and represents the probability of negative selection based on the number of substitutions occurring during evolution across primates. The mean <italic toggle="yes">phastCons20</italic> score ranges between 0 and 1, with a value of 0 meaning that the sequence is poorly conserved and 1 that the sequence is highly conserved.</p>
            </list-item>
            <list-item>
              <p>The mean context-dependent tolerance score (CDTS) (<xref rid="B26" ref-type="bibr">26</xref>) assigned to the 5’ and 3’ proximal exon-intron junction regions (Figure <xref rid="F1" ref-type="fig">1B</xref>). The CDTS score provides a measure of sequence constraint across individuals. This score ranges between -1 and 1, with negative values indicating regions of the human genome which have the lowest sequence variation across individuals.</p>
            </list-item>
            <list-item>
              <p>The maximum Transcript Support Level (TSL) assigned to the set of transcripts in which the annotated intron appears. This field can present one of the following values: 1, 2, 3, 4, 5 and tslNA. An intron with a <monospace>TSL = 1</monospace> value means that it has been found within a set of transcripts whose model presents the highest support available. On the contrary, an intron with a <monospace>TSL = 5</monospace> value means that it has been found within a set of transcripts with a poorly supported model structure. <monospace>TSL = tslNA</monospace>, means that none of the transcript structures in which the intron has been found is analysed (<ext-link xlink:href="https://www.ensembl.org/info/genome/genebuild/transcript_quality_tags.html" ext-link-type="uri">https://www.ensembl.org/info/genome/genebuild/transcript_quality_tags.html</ext-link>).</p>
            </list-item>
            <list-item>
              <p>Whether the annotated intron is likely to be spliced out from the pre-mRNA molecule by the major (column ‘<monospace>u2_intron = T</monospace>’) or minor spliceosome assembly (column ‘<monospace>u12_intron = T</monospace>’). This data was obtained from The Intron Annotation and Orthology Database (IAOD) (<xref rid="B32" ref-type="bibr">32</xref>). When these two columns are set to a <monospace>FALSE</monospace> value, it represents an annotated intron that was not categorised within the IAOD database.</p>
            </list-item>
          </list>
        </list-item>
        <list-item>
          <p><bold>Gene-level properties</bold>. It has been reported that the number of introns within a gene or its level of expression can affect the fitness cost of splicing errors (<xref rid="B33" ref-type="bibr">33</xref>). With this in mind, some gene-level properties have been incorporated into IntroVerse.</p>
          <list list-type="roman-lower">
            <list-item>
              <p>The gene length (in base pairs).</p>
            </list-item>
            <list-item>
              <p>The number of annotated transcripts assigned to the gene based on Ensembl v105.</p>
            </list-item>
            <list-item>
              <p>The median gene expression level (TPM) across all samples from each tissue and calculated using the getTPM()function from the R <monospace>recount</monospace> Bioconductor package version 1.22.0.</p>
            </list-item>
            <list-item>
              <p>The percentage of protein-coding transcripts in which each annotated intron was found. This percentage can be unreliable when a gene has many transcripts with low TSL values.</p>
            </list-item>
            <list-item>
              <p><monospace>Yes/no boolean</monospace> value to confirm whether the intron of interest forms part of a Matched Annotation from NCBI and EMBL-EBI (MANE) (<xref rid="B34" ref-type="bibr">34</xref>) Select transcript.</p>
            </list-item>
          </list>
        </list-item>
      </list>
      <p>The columns of the child tables contain information about the splicing activity of the annotated introns and novel junctions detected in each tissue:</p>
      <list list-type="alpha-lower">
        <list-item>
          <p>
            <bold>Annotated introns:</bold>
          </p>
          <list list-type="roman-lower">
            <list-item>
              <p>The rate of mis-splicing at donor and acceptor splice sites of the annotated intron as calculated by the <inline-formula><tex-math id="M00020" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$MS{R_D}$\end{document}</tex-math></inline-formula> and <inline-formula><tex-math id="M00021" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$MS{R_A}$\end{document}</tex-math></inline-formula> measures, which range between 0 and 1. Focusing on the <inline-formula><tex-math id="M00022" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$MS{R_D}$\end{document}</tex-math></inline-formula> measure, a <inline-formula><tex-math id="M00023" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$MS{R_D} = 0$\end{document}</tex-math></inline-formula> value represents accurate splicing at the 5’ splice site of the intron across all samples of the tissue studied, whereas a <inline-formula><tex-math id="M00024" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$MS{R_D} = 1$\end{document}</tex-math></inline-formula> value would represent complete mis-splicing at that splice site. It is worth noting that the <inline-formula><tex-math id="M00025" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$MSR$\end{document}</tex-math></inline-formula> metrics do not convey information about the certainty in the measure of mis-splicing, since annotated introns with low or high read coverage can generate similar <inline-formula><tex-math id="M00026" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$MSR$\end{document}</tex-math></inline-formula> values. With this in mind, the reader should consider additional metrics provided by IntroVerse such as the percentage of samples in which the intron was found and its mean coverage.</p>
            </list-item>
            <list-item>
              <p>The percentage of samples of a given tissue in which the annotated intron was used, as defined by ≥ 1 annotated read count in the sample.</p>
            </list-item>
            <list-item>
              <p>The mean number of annotated reads counts assigned to the annotated intron across all the samples.</p>
            </list-item>
          </list>
        </list-item>
        <list-item>
          <p><bold>Novel junctions</bold>:</p>
          <list list-type="roman-lower">
            <list-item>
              <p>The intron length in base pairs implied by the novel junction.</p>
            </list-item>
            <list-item>
              <p>The percentage of samples of a given tissue in which the novel junction was used, as defined by ≥ 1 novel junction read in the sample.</p>
            </list-item>
            <list-item>
              <p>The mean number of novel junction reads across all samples from a given tissue in which the novel junction was detected.</p>
            </list-item>
            <list-item>
              <p>The distance in base pairs between the genomic position of the unannotated splice site of the novel junction and the annotated acceptor/donor splice site of its paired annotated intron.</p>
            </list-item>
            <list-item>
              <p>Whether the novel junction is capable of causing a frameshift. This value has been calculated by obtaining the modulo 3 of the distance in base pairs lying between the genomic position of the unannotated splice site of the novel junction and the acceptor/donor splice site of its paired annotated intron. When the reminder of this division by 3 (i.e. modulo 3) returns a value of 1 or 2, it indicates that the excision of the novel intron would be capable of causing a frameshift.</p>
            </list-item>
            <list-item>
              <p>The strength of the 5’ and 3’ splicing signals implied by the novel junction, as calculated by the MaxEntScan (<xref rid="B24" ref-type="bibr">24</xref>) score algorithm.</p>
            </list-item>
          </list>
        </list-item>
      </list>
    </sec>
    <sec id="SEC2-5">
      <title>Web interface implementation</title>
      <p>A ShinyApp website was built and it uses the data stored in the IntroVerse SQLite database. The IntroVerse website was deployed using a Linux-based Apache/2.4.6 Web server running on a Docker container version 18.09.0 over a CentOS Linux release 7.5.1804 (Core) server. ShinyProxy (<ext-link xlink:href="https://www.shinyproxy.io/" ext-link-type="uri">https://www.shinyproxy.io/</ext-link>) was used as a proxy to allow multiple users to access IntroVerse simultaneously and to provide a fully isolated workspace per R session. Different in-house R scripts (DOI:10.5281/zenodo.6869186) were used to query the IntroVerse SQLite object from the IntroVerse Shiny app and return the information requested within a user-friendly format. Visualisation of the novel junctions as well as the mis-splicing activity occurring within the MANE Select transcript of a particular gene was made available through the use of the R package <monospace>ggtranscript</monospace> (<xref rid="B35" ref-type="bibr">35</xref>) version 0.99.9. The IntroVerse website was built using numerous client-side languages (HTML, CSS, JavaScript, JQuery) and libraries (JQuery.js, DataTable.js), as well as the Bootstrap version 4 framework (<ext-link xlink:href="https://getbootstrap.com/" ext-link-type="uri">https://getbootstrap.com/</ext-link>), which helped to enhance the look and feel of the user-interface and the user experience by supporting multiple devices, browsers and screen sizes. The IntroVerse website does not require registration or login for access and is freely available for research use and data download at <ext-link xlink:href="https://rytenlab.com/browser/app/introverse" ext-link-type="uri">https://rytenlab.com/browser/app/introverse</ext-link>. Finally, IntroVerse can also be downloaded as a docker image from <ext-link xlink:href="https://hub.docker.com/r/soniaruiz/introverse" ext-link-type="uri">https://hub.docker.com/r/soniaruiz/introverse</ext-link>.</p>
    </sec>
  </sec>
  <sec sec-type="results" id="SEC3">
    <title>RESULTS</title>
    <sec id="SEC3-1">
      <title>Database content and statistics</title>
      <p>We analysed 17,510 RNA-sequencing samples across 54 human tissues from GTEx v8 (<xref rid="B22" ref-type="bibr">22</xref>) with a median of 248 samples per tissue (ranging between 4 and 805 samples). All the split reads obtained from this dataset were annotated to the Ensembl v105 reference transcriptome. Of the split reads that passed the quality-control criteria (Figure <xref rid="F1" ref-type="fig">1C</xref>), we identified a total of 332,571 annotated introns of which 294,050 had evidence of at least one type of mis-splicing event, namely the use of a novel donor or novel acceptor junction in at least one of the 17,510 samples studied. The remaining 38,521 annotated introns corresponding to 14,395 genes within the database (44.06% of all genes analysed) had no evidence of mis-splicing across all tissues and samples processed (Figure <xref rid="F2" ref-type="fig">2B</xref>). Interestingly, of these 14,395 genes, we found that 10,081 were protein-coding and 3,584 were lncRNAs (with the remaining 730 being a mixture of other gene biotypes). Given that relatively few lncRNAs have known biological functions, this finding might suggest that IntroVerse could be used to identify the most important genes of this type. In fact, this view is supported by the finding that introns within lncRNA genes are more frequently mis-spliced at both the donor (Wilcoxon rank sum test with continuity correction, effect-size = 2.8e-2, <italic toggle="yes">P-</italic>value &lt; 2.2e−16) and acceptor splice sites (Wilcoxon rank sum test with continuity correction, effect-size = 3.03e-2, <italic toggle="yes">P-</italic>value &lt; 2.2e−16) than introns within protein-coding genes even after controlling for differences in read coverage (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S2</xref>). Therefore, when we identify lncRNAs which are perfectly spliced this could indicate a specific requirement for efficient degradation of mis-splicing events at this locus. With this in mind, we noted that the mouse homologue of the gene, <italic toggle="yes">FENDRR</italic>, a lncRNA containing multiple introns with no evidence of mis-splicing across samples from all tissues analysed, when knocked out results in postnatal lethality with defects in the lung, gastrointestinal tract and heart in <italic toggle="yes">Fendrr−/−</italic> neonates (<xref rid="B36" ref-type="bibr">36</xref>). Furthermore, since its essential role in mouse development was identified, <italic toggle="yes">FENDRR</italic> has also been implicated in multiple human cancers, supporting the utility of IntroVerse in prioritising lncRNAs for investigation (<xref rid="B37" ref-type="bibr">37</xref>).</p>
      <p>IntroVerse includes information on 1,950,821 novel donor and 2,728,653 novel acceptor junctions, which are confidently paired with the 294,050 annotated introns presenting evidence of at least one type of mis-splicing event across all tissues (Figure <xref rid="F2" ref-type="fig">2B</xref>). To summarise this data and provide a measure of mis-splicing across each annotated intron, we provide users with the measures, <inline-formula><tex-math id="M00027" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$MS{R_D}$\end{document}</tex-math></inline-formula> and <inline-formula><tex-math id="M00028" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$MS{R_A}$\end{document}</tex-math></inline-formula>. Focusing on samples from frontal cortex tissue, the median <inline-formula><tex-math id="M00029" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$MS{R_D}$\end{document}</tex-math></inline-formula> corresponded to 5e-4 [0−0.99], whereas the median <inline-formula><tex-math id="M00030" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$MS{R_A}$\end{document}</tex-math></inline-formula> was 1.3e-3 [0−0.99], though it is noteworthy that in both cases the modal values were zero indicating that splicing is largely accurate. Considering all tissues, the median <inline-formula><tex-math id="M00031" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$MS{R_D}$\end{document}</tex-math></inline-formula> was 8e-4 and the median <inline-formula><tex-math id="M00032" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$MS{R_A}$\end{document}</tex-math></inline-formula> was 1.7e-3, indicating that mis-splicing at the acceptor splice site is more common than that at the donor.</p>
    </sec>
    <sec id="SEC3-2">
      <title>Web interface and usage</title>
      <p>IntroVerse is a user-friendly and comprehensive website that allows users to browse and explore the characteristics of 332,571 annotated introns belonging to 32,669 different genes. The IntroVerse website consists of three major modules that allow users to (i) obtain information on the key characteristics and splicing accuracy of annotated introns across samples within each of the 54 GTEx v8 tissues, (ii) obtain information on the overall usage of novel junctions associated with an annotated intron of interest at both the donor and acceptor sites separately, and across each of the 54 GTEx tissues, and iii) visualise novel junctions and the rate of mis-splicing at donor and acceptor splice sites of annotated introns within the Matched Annotation from NCBI and EMBL-EBI (MANE) Select transcript (<xref rid="B34" ref-type="bibr">34</xref>) of a selected gene, and display it across all samples from a single or multiple tissues.</p>
      <sec id="SEC3-2-1">
        <title>Intron search</title>
        <p>To search for an annotated intron in IntroVerse within a tissue of interest, users can query the database by (i) introducing the coordinates of an annotated intron of interest (‘<italic toggle="yes">by intron coordinates’</italic>), (ii) selecting a gene symbol or gene ID from the dropdown list provided (<italic toggle="yes">‘by gene’</italic>) and (iii) uploading a gene list of interest (<italic toggle="yes">‘by gene list’</italic>) (Figure <xref rid="F4" ref-type="fig">4</xref>A-<xref rid="F1" ref-type="fig">1</xref>, Figure <xref rid="F4" ref-type="fig">4</xref>B-<xref rid="F1" ref-type="fig">1</xref>). The latter requires the user to upload a <italic toggle="yes">.csv</italic> file containing one single column with headers and a gene symbol or gene Ensembl ID per row. An example gene list is also provided. In all three cases, the information returned by IntroVerse consists of a table in which every entry represents an annotated intron in the reference transcriptome (Ensembl v105), with columns providing a range of key features about the annotated intron (see Materials and Methods, <italic toggle="yes">Database generation</italic>) and an additional blue button to show the mis-splicing activity attached to the intron (Figure <xref rid="F4" ref-type="fig">4</xref>B-<xref rid="F3" ref-type="fig">3</xref>).</p>
        <fig position="float" id="F4">
          <label>Figure 4.</label>
          <caption>
            <p>Basic functions of the IntroVerse web interface. (<bold>A</bold>) Overview of the main Search Panel available on the user interface of IntroVerse. (<bold>B</bold>) The displayed columns of the intron table correspond to: (i) ID, the unique identifier of the intron; (ii) Mis-spliced site, the splice site of the intron that has been mis-spliced if any; (iii) Intron Length, which represents the length of the intron in base pairs (bp); (iv) MES_5ss, the strength of the 5' (i.e. donor) splicing signal through the use of the MaxEntScan score algorithm; (v) Gene, the gene to which the intron belongs to; (vi) Samples, cluster of samples in which the intron search has been performed; (vii) More, button ‘Show Alternative Splicing Events’ to show the mis-splicing activity attached to the intron. (<bold>C</bold>) The columns of the novel junction table correspond to: (i) NovelID, the unique identifier of the novel junction; (ii) Novel Type, type of novel event, classified as ‘novel donor’ or ‘novel acceptor’; (iii) Junction Length (bp), implied intron length of the novel junction in base pairs; (iv) MES_5ss, the strength of the 5' (i.e. donor) splicing signal through the use of the MaxEntScan score algorithm; (v) MES_3ss, the strength of the 3' (i.e. acceptor) splicing signal through the use of the MaxEntScan score algorithm; (vi) Distance (bp), distance in base pairs between the novel junction and the paired annotated intron; (vii) More, button ‘Visualise in MANE transcript’ to display the graphical representation of the novel junction within the MANE transcript of the gene. (<bold>D</bold>) Visualisation of a novel donor event within the MANE transcript of a selected gene. Graphs can be downloaded in SVG format. (<bold>E</bold>) Visualisation of the mis-splicing activity occurring in all annotated introns within the MANE transcript of the selected gene. By clicking on the tab ‘Download’, it is possible to download the complete IntroVerse SQLite database.</p>
          </caption>
          <graphic xlink:href="gkac1056fig4" position="float"/>
        </fig>
        <p>IntroVerse also provides an advanced search section which enables the user to refine the query further. First, the <italic toggle="yes">‘Sample Selection’</italic> section (Figure <xref rid="F4" ref-type="fig">4</xref>A-<xref rid="F2" ref-type="fig">2</xref>) allows the user to determine whether the annotated intron search should be done across one single tissue, multiple tissues or <italic toggle="yes">‘All tissues’</italic>. This latter will produce an intron query across all 17,510 samples from the 54 human GTEx tissues processed. Second, the <italic toggle="yes">‘Support for novel annotation’</italic> section (Figure <xref rid="F4" ref-type="fig">4</xref>A-<xref rid="F3" ref-type="fig">3</xref>), contains a checkbox and a numeric range that filters the results to only show the annotated introns associated with at least one alternative splicing event shared across the minimum number of samples selected through the numeric range. This search is based on the hypothesis that for any novel junction to be indicative of the presence of a novel stable transcript (rather than mis-splicing), it should be shared across a high number of unrelated individuals. More specifically, we consider mis-splicing to be a random process making the likelihood of excising the same novel junction with the identical genomic positions across multiple unrelated individuals very low. Consequently, a specific novel junction that is detected across a high number of individuals (e.g. ≥ 90%) is more likely to be generated through a deliberate (non-random) process and to be of biological interest. Third, the <italic toggle="yes">‘Additional</italic><italic toggle="yes">Filters’</italic> section (Figure <xref rid="F4" ref-type="fig">4</xref>A-<xref rid="F4" ref-type="fig">4</xref>), provides two search refinements: (i) the <italic toggle="yes">‘Introns with ClinVar mutations’</italic> checkbox will only retrieve annotated introns that have been reported to contain at least one pathogenic or likely pathogenic splicing variant as defined within the ClinVar archive (<xref rid="B38" ref-type="bibr">38</xref>) and (ii) the <italic toggle="yes">‘Introns from MANE Select transcripts’</italic> checkbox will only report the introns from genes with a protein-coding transcript classified as MANE (<xref rid="B34" ref-type="bibr">34</xref>) in the reference annotation.</p>
      </sec>
      <sec id="SEC3-2-2">
        <title>Mis-splicing search</title>
        <p>All alternative splicing events that are associated with an annotated intron of interest can be retrieved by clicking the blue button <italic toggle="yes">‘Show Alternative Splicing Events’</italic> located at the end of every row of the annotated Intron table (Figure <xref rid="F4" ref-type="fig">4</xref>B-<xref rid="F3" ref-type="fig">3</xref>, Figure <xref rid="F4" ref-type="fig">4</xref>C-<xref rid="F1" ref-type="fig">1</xref>). Clicking this button will automatically hide all rows except those selected and will result in the display of an additional table consisting of all alternative splicing events paired with the annotated intron of interest. In this second table, every entry represents a unique alternative splicing as identified through novel junctions. The columns provide key information about the novel event itself (see Materials and Methods, <italic toggle="yes">Database generation</italic>), and an additional button <italic toggle="yes">‘Visualise in MANE transcript’</italic> (Figure <xref rid="F4" ref-type="fig">4</xref>C-<xref rid="F2" ref-type="fig">2</xref>) which when clicked will trigger a popup window with the graphical representation of the novel junction within the MANE transcript of the gene (Figure <xref rid="F4" ref-type="fig">4D</xref>). This visualisation will highlight the related novel donor (blue) or novel acceptor junctions (red) within the gene's MANE (<xref rid="B34" ref-type="bibr">34</xref>) transcript.</p>
      </sec>
      <sec id="SEC3-2-3">
        <title>Gene mis-splicing visualisation</title>
        <p>IntroVerse provides the option to visualise mis-splicing rates across all annotated introns contained within the MANE transcript of a gene of interest (Figure <xref rid="F4" ref-type="fig">4</xref>E-<xref rid="F1" ref-type="fig">1</xref>) in a given tissue. The mis-splicing rate as defined by the <inline-formula><tex-math id="M00033" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$MS{R_D}$\end{document}</tex-math></inline-formula> and the <inline-formula><tex-math id="M00034" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$MS{R_A}$\end{document}</tex-math></inline-formula> values are represented by blue and red vertical bars respectively located at the 5’ splice (<inline-formula><tex-math id="M00035" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$MS{R_D}$\end{document}</tex-math></inline-formula>) or 3’ splice sites (<inline-formula><tex-math id="M00036" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$MS{R_A}$\end{document}</tex-math></inline-formula>). Since <inline-formula><tex-math id="M00037" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$MS{R_D}$\end{document}</tex-math></inline-formula> and <inline-formula><tex-math id="M00038" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$MS{R_A}$\end{document}</tex-math></inline-formula> are normalised to range between a value of 0 and 1, the higher the vertical bar displayed, the higher the proportion of novel junction reads paired to the annotated intron at that splice site. This visualisation allows the user to quickly identify annotated introns within the MANE transcript that are most frequently mis-spliced across samples of single or multiple tissues, with the latter enabling the identification of tissue-specific mis-splicing activity.</p>
      </sec>
    </sec>
    <sec id="SEC3-3">
      <title>Data download and visualisation</title>
      <p>IntroVerse provides functionality for both data download and visualisation purposes. Data tables containing annotated introns and novel junctions can be fully downloaded in PDF, CSV, Excel and Text formats (Figure <xref rid="F4" ref-type="fig">4</xref>B-<xref rid="F4" ref-type="fig">4</xref>, Figure <xref rid="F4" ref-type="fig">4</xref>C-<xref rid="F3" ref-type="fig">3</xref>). Depending on the table selected, every entry will represent either an annotated intron or a novel junction, and the columns will contain key information about each feature (see Materials and Methods, <italic toggle="yes">Database generation</italic>) with the user being able to select only a subset of features as required. Data visualisation is provided for novel junctions as well as for mis-splicing activity across all annotated introns within the MANE transcript of a selected gene. Visualisation for novel junctions can be downloaded in SVG format (Figure <xref rid="F4" ref-type="fig">4</xref>D-<xref rid="F1" ref-type="fig">1</xref>). The complete SQLite database can be downloaded directly from the user interface of IntroVerse along with other useful resources such as the SQL schema and a set of handy SQL queries (Figure <xref rid="F4" ref-type="fig">4</xref>E-<xref rid="F2" ref-type="fig">2</xref>). The IntroVerse database has been carefully designed to be highly efficient such that the entire database currently occupies less than 3GB.</p>
    </sec>
  </sec>
  <sec id="SEC4">
    <title>APPLICATIONS</title>
    <p>IntroVerse has multiple use cases and some of them are listed below:</p>
    <list list-type="order">
      <list-item>
        <p>The assessment of background levels of mis-splicing amongst control individuals within introns thought to be mis-spliced in disease states. We found that introns containing pathogenic or likely pathogenic splice site mutations (as defined within ClinVar, <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/variation/view" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/variation/view</ext-link>) have significantly lower <inline-formula><tex-math id="M00039" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$MS{R_D}$\end{document}</tex-math></inline-formula> (Wilcoxon rank sum test with continuity correction, effect-size = 5.78e-2, <italic toggle="yes">P-</italic>value &lt; 2.2e−16) and <inline-formula><tex-math id="M00040" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$MS{R_A}$\end{document}</tex-math></inline-formula> (Wilcoxon rank sum test with continuity correction, effect-size = 6.74e-2, <italic toggle="yes">P-</italic>value &lt; 2.2e−16) values across all tissues than other annotated introns not containing any ClinVar variant after controlling for mean read coverage (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S3</xref>). This suggests that, in control individuals, annotated introns containing pathogenic variants are spliced with particularly high accuracy.</p>
      </list-item>
      <list-item>
        <p>Identification of novel transcripts of known genes and their tissue-specific usage: Using samples from frontal cortex tissue, we detected 2,048 novel junctions corresponding to 1,420 genes which are used in &gt; 80% of samples (<italic toggle="yes">N</italic> = 167), suggesting the existence of incomplete annotation at these specific sites. Importantly, we found that the discovery of such sites was only weakly correlated with read coverage over the annotated intron (<italic toggle="yes">R</italic><sup>2</sup> = 3.7e-2, <italic toggle="yes">P-</italic>value &lt; 2e−16, <xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S1</xref>). Furthermore, by using the filter <italic toggle="yes">‘Support for novel annotation’</italic>, which is available on the main user interface of IntroVerse, we noted that of all green genes (<italic toggle="yes">N</italic> = 121) causally implicated in hereditary ataxia (as defined in PanelApp Version 1.303, <ext-link xlink:href="https://panelapp.genomicsengland.co.uk/" ext-link-type="uri">https://panelapp.genomicsengland.co.uk/</ext-link>), 17% (<italic toggle="yes">N</italic> = 21) contain novel junctions which are used in ≥ 80% of cerebellar samples (<italic toggle="yes">N</italic> = 217).</p>
      </list-item>
      <list-item>
        <p>Integration of short- and long-read RNA-sequencing data to support novel transcript discovery: Using untargeted long-read RNA-sequencing data provided by the ENCODE project and relating to N = 16 samples of the human heart (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S2</xref>), we identified all novel junctions absent from Ensembl v105. Of the 611 unique novel junctions found across all sixteen ENCODE samples, we found that 349 were also detected in GTEx v8 left ventricle and atrial appendage heart tissues as stored in IntroVerse. Furthermore, these 342 novel junctions were detected in a median of 353 left ventricle and atrial appendage GTEx samples suggesting that the full-length transcripts from which they are derived are likely to be novel transcripts of known genes.</p>
      </list-item>
    </list>
  </sec>
  <sec sec-type="discussion" id="SEC5">
    <title>DISCUSSION</title>
    <p>IntroVerse provides quality-controlled information on the splicing of 332,571 annotated introns from 32,669 different genes across 17,510 RNA-sequencing samples and 54 human control tissues. IntroVerse has two unique features: (i) it provides a complete and unfiltered catalogue of novel junctions that have been carefully processed and quality-controlled and (ii) each novel junction has been assigned to a specific annotated intron, which provides a hierarchical structure allowing the user to start by browsing a gene or genomic position of interest and to end with an exploration of the complete catalogue of alternative events occurring at that locus. In addition, IntroVerse allows users to browse, download and compare key genomic parameters either across introns of a particular gene and sample of interest or across multiple genes, samples and human tissues. Finally, to the best of our knowledge, IntroVerse is the only database that enables the visualisation of alternative splicing events by i) displaying individual events in the context of the gene's MANE transcript and ii) the overall frequency of alternative splicing of each annotated intron of the gene's MANE transcript.</p>
    <p>Future versions of this database will include additional human RNA-sequencing data sets generated from individuals with disease, in addition to controls. More specifically, we will include data provided by the BrainSEQ Consortium Phase I and II projects (<xref rid="B39" ref-type="bibr">39–41</xref>), which have generated RNA-sequencing data from more than 700 human brain samples across the lifespan and derived from individuals with major neuropsychiatric disorders. With the increasing availability of untargeted long-read RNA-sequencing data, we will also expand the annotation of novel junctions within IntroVerse to flag when a junction is also identified within public long-read RNA-sequencing data and the related full-length transcript/s. These future updates will increase the value of IntroVerse and broaden its applications.</p>
    <p>Thus, IntroVerse provides users with structured data on intron usage across a wide range of human tissues which can be used in a range of downstream analyses to improve our understanding of the role of splicing in health and disease.</p>
  </sec>
  <sec sec-type="data-availability" id="SEC6">
    <title>DATA AVAILABILITY</title>
    <p>IntroVerse is a user-friendly and comprehensive website that is fed from an SQLite database containing the splicing activity of 332,571 annotated introns found across 17,510 RNA-sequencing samples from 54 control tissues. The complete SQLite database is available to be downloaded directly from the user interface of IntroVerse, as it has been carefully designed to be highly efficient such that the entire database currently only occupies less than 3GB.</p>
    <p>IntroVerse is available for data-querying and download purposes at <ext-link xlink:href="https://rytenlab.com/browser/app/introverse" ext-link-type="uri">https://rytenlab.com/browser/app/introverse</ext-link>. Multiple in-house R scripts have been created to query the IntroVerse SQLite object from the IntroVerse Shiny app, as well as to build the latter. These scripts are freely available on GitHub (<underline>DOI:10.5281/zenodo.6869186</underline>).</p>
    <p>Finally, IntroVerse is also available in docker formatting at <ext-link xlink:href="https://hub.docker.com/r/soniaruiz/introverse" ext-link-type="uri">https://hub.docker.com/r/soniaruiz/introverse</ext-link>.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="sup1" position="float" content-type="local-data">
      <label>gkac1056_Supplemental_File</label>
      <media xlink:href="gkac1056_supplemental_file.pdf">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <sec id="SEC7">
    <title>SUPPLEMENTARY DATA</title>
    <p><ext-link xlink:href="https://academic.oup.com/nar/article-lookup/doi/10.1093/nar/gkac1056#supplementary-data" ext-link-type="uri">Supplementary Data</ext-link> are available at NAR Online.</p>
  </sec>
  <sec id="SEC8">
    <title>FUNDING</title>
    <p>All data processing was performed in the cloud using a virtual instance type <italic toggle="yes">m6i.8xlarge</italic> provided by the AWS Web Services (AWS) Elastic Cloud service and funded through the award of AWS Cloud Credit for Research (to S.G.R.). S.G.R., D.Z. and M.R. were supported through the award of a Tenure Track Clinician Scientist Fellowship [MR/N008324/1 to M.R.]; E.K.G. was supported by the Postdoctoral Fellowship Program in Alzheimer's Disease Research from the BrightFocus Foundation [A2021009F]; Z.C. was supported by a clinical research fellowship from the Leonard Wolfson Foundation; A.F.-B. was supported through the award of a Biotechnology and Biological Sciences Research Council (BBSRC UK) London Interdisciplinary Doctoral Fellowship; A.L.G.-M. was supported by Fundación Séneca [21230/PD/19]; J.B. was supported through the Science and Technology Agency, Séneca Foundation, CARM, Spain (research project 00007/COVI/20); L.C.-T. was supported by the National Institutes of Health (United States) [R01MH123567]. Funding for open access charge: Discretionary funds of corresponding author.</p>
    <p><italic toggle="yes">Conflict of interest statement</italic>. None declared.</p>
  </sec>
  <ref-list id="REF1">
    <title>REFERENCES</title>
    <ref id="B1">
      <label>1.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Berget</surname><given-names>S.M.</given-names></string-name>, <string-name><surname>Moore</surname><given-names>C.</given-names></string-name>, <string-name><surname>Sharp</surname><given-names>P.A.</given-names></string-name></person-group><article-title>Spliced segments at the 5’ terminus of adenovirus 2 late mRNA</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source><year>1977</year>; <volume>74</volume>:<fpage>3171</fpage>–<lpage>3175</lpage>.<pub-id pub-id-type="pmid">269380</pub-id></mixed-citation>
    </ref>
    <ref id="B2">
      <label>2.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chow</surname><given-names>L.T.</given-names></string-name>, <string-name><surname>Gelinas</surname><given-names>R.E.</given-names></string-name>, <string-name><surname>Broker</surname><given-names>T.R.</given-names></string-name>, <string-name><surname>Roberts</surname><given-names>R.J.</given-names></string-name></person-group><article-title>An amazing sequence arrangement at the 5’ ends of adenovirus 2 messenger RNA</article-title>. <source>Cell</source>. <year>1977</year>; <volume>12</volume>:<fpage>1</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">902310</pub-id></mixed-citation>
    </ref>
    <ref id="B3">
      <label>3.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>E.T.</given-names></string-name>, <string-name><surname>Sandberg</surname><given-names>R.</given-names></string-name>, <string-name><surname>Luo</surname><given-names>S.</given-names></string-name>, <string-name><surname>Khrebtukova</surname><given-names>I.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>L.</given-names></string-name>, <string-name><surname>Mayr</surname><given-names>C.</given-names></string-name>, <string-name><surname>Kingsmore</surname><given-names>S.F.</given-names></string-name>, <string-name><surname>Schroth</surname><given-names>G.P.</given-names></string-name>, <string-name><surname>Burge</surname><given-names>C.B.</given-names></string-name></person-group><article-title>Alternative isoform regulation in human tissue transcriptomes</article-title>. <source>Nature</source>. <year>2008</year>; <volume>456</volume>:<fpage>470</fpage>–<lpage>476</lpage>.<pub-id pub-id-type="pmid">18978772</pub-id></mixed-citation>
    </ref>
    <ref id="B4">
      <label>4.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pan</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Shai</surname><given-names>O.</given-names></string-name>, <string-name><surname>Lee</surname><given-names>L.J.</given-names></string-name>, <string-name><surname>Frey</surname><given-names>B.J.</given-names></string-name>, <string-name><surname>Blencowe</surname><given-names>B.J.</given-names></string-name></person-group><article-title>Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing</article-title>. <source>Nat. Genet.</source><year>2008</year>; <volume>40</volume>:<fpage>1413</fpage>–<lpage>1415</lpage>.<pub-id pub-id-type="pmid">18978789</pub-id></mixed-citation>
    </ref>
    <ref id="B5">
      <label>5.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lord</surname><given-names>J.</given-names></string-name>, <string-name><surname>Baralle</surname><given-names>D.</given-names></string-name></person-group><article-title>Splicing in the diagnosis of rare disease: advances and challenges</article-title>. <source>Front. Genet.</source><year>2021</year>; <volume>12</volume>:<fpage>689892</fpage>.<pub-id pub-id-type="pmid">34276790</pub-id></mixed-citation>
    </ref>
    <ref id="B6">
      <label>6.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Scotti</surname><given-names>M.M.</given-names></string-name>, <string-name><surname>Swanson</surname><given-names>M.S.</given-names></string-name></person-group><article-title>RNA mis-splicing in disease</article-title>. <source>Nat. Rev. Genet.</source><year>2016</year>; <volume>17</volume>:<fpage>19</fpage>–<lpage>32</lpage>.<pub-id pub-id-type="pmid">26593421</pub-id></mixed-citation>
    </ref>
    <ref id="B7">
      <label>7.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Douglas</surname><given-names>A.G.L.</given-names></string-name>, <string-name><surname>Wood</surname><given-names>M.J.A.</given-names></string-name></person-group><article-title>RNA splicing: disease and therapy</article-title>. <source>Brief. Funct. Genomics</source>. <year>2011</year>; <volume>10</volume>:<fpage>151</fpage>–<lpage>164</lpage>.<pub-id pub-id-type="pmid">21628314</pub-id></mixed-citation>
    </ref>
    <ref id="B8">
      <label>8.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Gerstein</surname><given-names>M.</given-names></string-name>, <string-name><surname>Snyder</surname><given-names>M.</given-names></string-name></person-group><article-title>RNA-Seq: a revolutionary tool for transcriptomics</article-title>. <source>Nat. Rev. Genet.</source><year>2009</year>; <volume>10</volume>:<fpage>57</fpage>–<lpage>63</lpage>.<pub-id pub-id-type="pmid">19015660</pub-id></mixed-citation>
    </ref>
    <ref id="B9">
      <label>9.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Lai</surname><given-names>H.</given-names></string-name>, <string-name><surname>Li</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>B.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>S.</given-names></string-name>, <string-name><surname>Li</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Huang</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Meng</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>P.</given-names></string-name>, <string-name><surname>Hu</surname><given-names>Z.</given-names></string-name><etal>et al</etal>.</person-group><article-title>RJunBase: a database of RNA splice junctions in human normal and cancerous tissues</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>; <volume>49</volume>:<fpage>D201</fpage>–<lpage>D211</lpage>.<pub-id pub-id-type="pmid">33179749</pub-id></mixed-citation>
    </ref>
    <ref id="B10">
      <label>10.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tapial</surname><given-names>J.</given-names></string-name>, <string-name><surname>Ha</surname><given-names>K.C.H.</given-names></string-name>, <string-name><surname>Sterne-Weiler</surname><given-names>T.</given-names></string-name>, <string-name><surname>Gohr</surname><given-names>A.</given-names></string-name>, <string-name><surname>Braunschweig</surname><given-names>U.</given-names></string-name>, <string-name><surname>Hermoso-Pulido</surname><given-names>A.</given-names></string-name>, <string-name><surname>Quesnel-Vallières</surname><given-names>M.</given-names></string-name>, <string-name><surname>Permanyer</surname><given-names>J.</given-names></string-name>, <string-name><surname>Sodaei</surname><given-names>R.</given-names></string-name>, <string-name><surname>Marquez</surname><given-names>Y.</given-names></string-name><etal>et al</etal>.</person-group><article-title>An atlas of alternative splicing profiles and functional associations reveals new regulatory programs and genes that simultaneously express multiple major isoforms</article-title>. <source>Genome Res.</source><year>2017</year>; <volume>27</volume>:<fpage>1759</fpage>–<lpage>1768</lpage>.<pub-id pub-id-type="pmid">28855263</pub-id></mixed-citation>
    </ref>
    <ref id="B11">
      <label>11.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hyung</surname><given-names>D.</given-names></string-name>, <string-name><surname>Kim</surname><given-names>J.</given-names></string-name>, <string-name><surname>Cho</surname><given-names>S.Y.</given-names></string-name>, <string-name><surname>Park</surname><given-names>C.</given-names></string-name></person-group><article-title>ASpedia: a comprehensive encyclopedia of human alternative splicing</article-title>. <source>Nucleic Acids Res.</source><year>2018</year>; <volume>46</volume>:<fpage>D58</fpage>–<lpage>D63</lpage>.<pub-id pub-id-type="pmid">29106599</pub-id></mixed-citation>
    </ref>
    <ref id="B12">
      <label>12.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Takeda</surname><given-names>J.</given-names></string-name>, <string-name><surname>Suzuki</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Nakao</surname><given-names>M.</given-names></string-name>, <string-name><surname>Kuroda</surname><given-names>T.</given-names></string-name>, <string-name><surname>Sugano</surname><given-names>S.</given-names></string-name>, <string-name><surname>Gojobori</surname><given-names>T.</given-names></string-name>, <string-name><surname>Imanishi</surname><given-names>T.</given-names></string-name></person-group><article-title>H-DBAS: alternative splicing database of completely sequenced and manually annotated full-length cDNAs based on H-Invitational</article-title>. <source>Nucleic Acids Res.</source><year>2007</year>; <volume>35</volume>:<fpage>D104</fpage>–<lpage>D109</lpage>.<pub-id pub-id-type="pmid">17130147</pub-id></mixed-citation>
    </ref>
    <ref id="B13">
      <label>13.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hiller</surname><given-names>M.</given-names></string-name>, <string-name><surname>Nikolajewa</surname><given-names>S.</given-names></string-name>, <string-name><surname>Huse</surname><given-names>K.</given-names></string-name>, <string-name><surname>Szafranski</surname><given-names>K.</given-names></string-name>, <string-name><surname>Rosenstiel</surname><given-names>P.</given-names></string-name>, <string-name><surname>Schuster</surname><given-names>S.</given-names></string-name>, <string-name><surname>Backofen</surname><given-names>R.</given-names></string-name>, <string-name><surname>Platzer</surname><given-names>M.</given-names></string-name></person-group><article-title>TassDB: a database of alternative tandem splice sites</article-title>. <source>Nucleic Acids Res.</source><year>2007</year>; <volume>35</volume>:<fpage>D188</fpage>–<lpage>D192</lpage>.<pub-id pub-id-type="pmid">17142241</pub-id></mixed-citation>
    </ref>
    <ref id="B14">
      <label>14.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nellore</surname><given-names>A.</given-names></string-name>, <string-name><surname>Jaffe</surname><given-names>A.E.</given-names></string-name>, <string-name><surname>Fortin</surname><given-names>J.-P.</given-names></string-name>, <string-name><surname>Alquicira-Hernández</surname><given-names>J.</given-names></string-name>, <string-name><surname>Collado-Torres</surname><given-names>L.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>S.</given-names></string-name>, <string-name><surname>Phillips</surname><given-names>R.A.</given-names></string-name>, <string-name><surname>Karbhari</surname><given-names>N.</given-names></string-name>, <string-name><surname>Hansen</surname><given-names>K.D.</given-names></string-name>, <string-name><surname>Langmead</surname><given-names>B.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Human splicing diversity and the extent of unannotated splice junctions across human RNA-seq samples on the sequence read archive</article-title>. <source>Genome Biol.</source><year>2016</year>; <volume>17</volume>:<fpage>266</fpage>.<pub-id pub-id-type="pmid">28038678</pub-id></mixed-citation>
    </ref>
    <ref id="B15">
      <label>15.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Holste</surname><given-names>D.</given-names></string-name>, <string-name><surname>Huo</surname><given-names>G.</given-names></string-name>, <string-name><surname>Tung</surname><given-names>V.</given-names></string-name>, <string-name><surname>Burge</surname><given-names>C.B.</given-names></string-name></person-group><article-title>HOLLYWOOD: a comparative relational database of alternative splicing</article-title>. <source>Nucleic Acids Res.</source><year>2006</year>; <volume>34</volume>:<fpage>D56</fpage>–<lpage>D62</lpage>.<pub-id pub-id-type="pmid">16381932</pub-id></mixed-citation>
    </ref>
    <ref id="B16">
      <label>16.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wan</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Larson</surname><given-names>D.R.</given-names></string-name></person-group><article-title>Splicing heterogeneity: separating signal from noise</article-title>. <source>Genome Biol.</source><year>2018</year>; <volume>19</volume>:<fpage>86</fpage>.<pub-id pub-id-type="pmid">29986741</pub-id></mixed-citation>
    </ref>
    <ref id="B17">
      <label>17.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Melamud</surname><given-names>E.</given-names></string-name>, <string-name><surname>Moult</surname><given-names>J.</given-names></string-name></person-group><article-title>Stochastic noise in splicing machinery</article-title>. <source>Nucleic Acids Res.</source><year>2009</year>; <volume>37</volume>:<fpage>4873</fpage>–<lpage>4886</lpage>.<pub-id pub-id-type="pmid">19546110</pub-id></mixed-citation>
    </ref>
    <ref id="B18">
      <label>18.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Giaretta</surname><given-names>A.</given-names></string-name></person-group><article-title>Stochasticity in transcriptional, splicing and translational regulations in time and frequency domains</article-title>. <source>BioSystems</source>. <year>2022</year>; <volume>212</volume>:<fpage>104595</fpage>.<pub-id pub-id-type="pmid">35026321</pub-id></mixed-citation>
    </ref>
    <ref id="B19">
      <label>19.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pickrell</surname><given-names>J.K.</given-names></string-name>, <string-name><surname>Pai</surname><given-names>A.A.</given-names></string-name>, <string-name><surname>Gilad</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Pritchard</surname><given-names>J.K.</given-names></string-name></person-group><article-title>Noisy splicing drives mRNA isoform diversity in human cells</article-title>. <source>PLoS Genet.</source><year>2010</year>; <volume>6</volume>:<fpage>e1001236</fpage>.<pub-id pub-id-type="pmid">21151575</pub-id></mixed-citation>
    </ref>
    <ref id="B20">
      <label>20.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Marco-Puche</surname><given-names>G.</given-names></string-name>, <string-name><surname>Lois</surname><given-names>S.</given-names></string-name>, <string-name><surname>Benítez</surname><given-names>J.</given-names></string-name>, <string-name><surname>Trivino</surname><given-names>J.C.</given-names></string-name></person-group><article-title>RNA-Seq perspectives to improve clinical diagnosis</article-title>. <source>Front. Genet.</source><year>2019</year>; <volume>10</volume>:<fpage>1152</fpage>.<pub-id pub-id-type="pmid">31781178</pub-id></mixed-citation>
    </ref>
    <ref id="B21">
      <label>21.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kuo</surname><given-names>R.I.</given-names></string-name>, <string-name><surname>Cheng</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>R.</given-names></string-name>, <string-name><surname>Brown</surname><given-names>W.S.</given-names></string-name>, <string-name><surname>Smith</surname><given-names>J.</given-names></string-name>, <string-name><surname>Archibald</surname><given-names>A.L.</given-names></string-name>, <string-name><surname>Burt</surname><given-names>D.W.</given-names></string-name></person-group><article-title>Illuminating the dark side of the human transcriptome with long read transcript sequencing</article-title>. <source>BMC Genomics</source>. <year>2020</year>; <volume>21</volume>:<fpage>751</fpage>.<pub-id pub-id-type="pmid">33126848</pub-id></mixed-citation>
    </ref>
    <ref id="B22">
      <label>22.</label>
      <mixed-citation publication-type="journal"><collab>GTEx Consortium</collab><article-title>The GTEx consortium atlas of genetic regulatory effects across human tissues</article-title>. <source>Science</source>. <year>2020</year>; <volume>369</volume>:<fpage>1318</fpage>–<lpage>1330</lpage>.<pub-id pub-id-type="pmid">32913098</pub-id></mixed-citation>
    </ref>
    <ref id="B23">
      <label>23.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wilks</surname><given-names>C.</given-names></string-name>, <string-name><surname>Zheng</surname><given-names>S.C.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>F.Y.</given-names></string-name>, <string-name><surname>Charles</surname><given-names>R.</given-names></string-name>, <string-name><surname>Solomon</surname><given-names>B.</given-names></string-name>, <string-name><surname>Ling</surname><given-names>J.P.</given-names></string-name>, <string-name><surname>Imada</surname><given-names>E.L.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>D.</given-names></string-name>, <string-name><surname>Joseph</surname><given-names>L.</given-names></string-name>, <string-name><surname>Leek</surname><given-names>J.T.</given-names></string-name><etal>et al</etal>.</person-group><article-title>recount3: summaries and queries for large-scale RNA-seq expression and splicing</article-title>. <source>Genome Biol.</source><year>2021</year>; <volume>22</volume>:<fpage>323</fpage>.<pub-id pub-id-type="pmid">34844637</pub-id></mixed-citation>
    </ref>
    <ref id="B24">
      <label>24.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yeo</surname><given-names>G.</given-names></string-name>, <string-name><surname>Burge</surname><given-names>C.B.</given-names></string-name></person-group><article-title>Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals</article-title>. <source>J. Comput. Biol.</source><year>2004</year>; <volume>11</volume>:<fpage>377</fpage>–<lpage>394</lpage>.<pub-id pub-id-type="pmid">15285897</pub-id></mixed-citation>
    </ref>
    <ref id="B25">
      <label>25.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Siepel</surname><given-names>A.</given-names></string-name>, <string-name><surname>Bejerano</surname><given-names>G.</given-names></string-name>, <string-name><surname>Pedersen</surname><given-names>J.S.</given-names></string-name>, <string-name><surname>Hinrichs</surname><given-names>A.S.</given-names></string-name>, <string-name><surname>Hou</surname><given-names>M.</given-names></string-name>, <string-name><surname>Rosenbloom</surname><given-names>K.</given-names></string-name>, <string-name><surname>Clawson</surname><given-names>H.</given-names></string-name>, <string-name><surname>Spieth</surname><given-names>J.</given-names></string-name>, <string-name><surname>Hillier</surname><given-names>L.W.</given-names></string-name>, <string-name><surname>Richards</surname><given-names>S.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes</article-title>. <source>Genome Res.</source><year>2005</year>; <volume>15</volume>:<fpage>1034</fpage>–<lpage>1050</lpage>.<pub-id pub-id-type="pmid">16024819</pub-id></mixed-citation>
    </ref>
    <ref id="B26">
      <label>26.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>di Iulio</surname><given-names>J.</given-names></string-name>, <string-name><surname>Bartha</surname><given-names>I.</given-names></string-name>, <string-name><surname>Wong</surname><given-names>E.H.M.</given-names></string-name>, <string-name><surname>Yu</surname><given-names>H.-C.</given-names></string-name>, <string-name><surname>Lavrenko</surname><given-names>V.</given-names></string-name>, <string-name><surname>Yang</surname><given-names>D.</given-names></string-name>, <string-name><surname>Jung</surname><given-names>I.</given-names></string-name>, <string-name><surname>Hicks</surname><given-names>M.A.</given-names></string-name>, <string-name><surname>Shah</surname><given-names>N.</given-names></string-name>, <string-name><surname>Kirkness</surname><given-names>E.F.</given-names></string-name><etal>et al</etal>.</person-group><article-title>The human noncoding genome defined by genetic diversity</article-title>. <source>Nat. Genet.</source><year>2018</year>; <volume>50</volume>:<fpage>333</fpage>–<lpage>337</lpage>.<pub-id pub-id-type="pmid">29483654</pub-id></mixed-citation>
    </ref>
    <ref id="B27">
      <label>27.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dobin</surname><given-names>A.</given-names></string-name>, <string-name><surname>Gingeras</surname><given-names>T.R.</given-names></string-name></person-group><article-title>Optimizing RNA-Seq mapping with STAR</article-title>. <source>Methods Mol. Biol.</source><year>2016</year>; <volume>1415</volume>:<fpage>245</fpage>–<lpage>262</lpage>.<pub-id pub-id-type="pmid">27115637</pub-id></mixed-citation>
    </ref>
    <ref id="B28">
      <label>28.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wilks</surname><given-names>C.</given-names></string-name>, <string-name><surname>Ahmed</surname><given-names>O.</given-names></string-name>, <string-name><surname>Baker</surname><given-names>D.N.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>D.</given-names></string-name>, <string-name><surname>Collado-Torres</surname><given-names>L.</given-names></string-name>, <string-name><surname>Langmead</surname><given-names>B.</given-names></string-name></person-group><article-title>Megadepth: efficient coverage quantification for bigwigs and BAMs</article-title>. <source>Bioinformatics</source>. <year>2021</year>; <volume>37</volume>:<fpage>3014</fpage>–<lpage>3016</lpage>.<pub-id pub-id-type="pmid">33693500</pub-id></mixed-citation>
    </ref>
    <ref id="B29">
      <label>29.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Taggart</surname><given-names>A.J.</given-names></string-name>, <string-name><surname>Lin</surname><given-names>C.-L.</given-names></string-name>, <string-name><surname>Shrestha</surname><given-names>B.</given-names></string-name>, <string-name><surname>Heintzelman</surname><given-names>C.</given-names></string-name>, <string-name><surname>Kim</surname><given-names>S.</given-names></string-name>, <string-name><surname>Fairbrother</surname><given-names>W.G.</given-names></string-name></person-group><article-title>Large-scale analysis of branchpoint usage across species and cell lines</article-title>. <source>Genome Res.</source><year>2017</year>; <volume>27</volume>:<fpage>639</fpage>–<lpage>649</lpage>.<pub-id pub-id-type="pmid">28119336</pub-id></mixed-citation>
    </ref>
    <ref id="B30">
      <label>30.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Amemiya</surname><given-names>H.M.</given-names></string-name>, <string-name><surname>Kundaje</surname><given-names>A.</given-names></string-name>, <string-name><surname>Boyle</surname><given-names>A.P.</given-names></string-name></person-group><article-title>The ENCODE blacklist: identification of problematic regions of the genome</article-title>. <source>Sci. Rep.</source><year>2019</year>; <volume>9</volume>:<fpage>9354</fpage>.<pub-id pub-id-type="pmid">31249361</pub-id></mixed-citation>
    </ref>
    <ref id="B31">
      <label>31.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dillies</surname><given-names>M.-A.</given-names></string-name>, <string-name><surname>Rau</surname><given-names>A.</given-names></string-name>, <string-name><surname>Aubert</surname><given-names>J.</given-names></string-name>, <string-name><surname>Hennequet-Antier</surname><given-names>C.</given-names></string-name>, <string-name><surname>Jeanmougin</surname><given-names>M.</given-names></string-name>, <string-name><surname>Servant</surname><given-names>N.</given-names></string-name>, <string-name><surname>Keime</surname><given-names>C.</given-names></string-name>, <string-name><surname>Marot</surname><given-names>G.</given-names></string-name>, <string-name><surname>Castel</surname><given-names>D.</given-names></string-name>, <string-name><surname>Estelle</surname><given-names>J.</given-names></string-name><etal>et al</etal>.</person-group><article-title>A comprehensive evaluation of normalization methods for illumina high-throughput RNA sequencing data analysis</article-title>. <source>Brief. Bioinformatics</source>. <year>2013</year>; <volume>14</volume>:<fpage>671</fpage>–<lpage>683</lpage>.<pub-id pub-id-type="pmid">22988256</pub-id></mixed-citation>
    </ref>
    <ref id="B32">
      <label>32.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Moyer</surname><given-names>D.C.</given-names></string-name>, <string-name><surname>Larue</surname><given-names>G.E.</given-names></string-name>, <string-name><surname>Hershberger</surname><given-names>C.E.</given-names></string-name>, <string-name><surname>Roy</surname><given-names>S.W.</given-names></string-name>, <string-name><surname>Padgett</surname><given-names>R.A.</given-names></string-name></person-group><article-title>Comprehensive database and evolutionary dynamics of U12-type introns</article-title>. <source>Nucleic Acids Res.</source><year>2020</year>; <volume>48</volume>:<fpage>7066</fpage>–<lpage>7078</lpage>.<pub-id pub-id-type="pmid">32484558</pub-id></mixed-citation>
    </ref>
    <ref id="B33">
      <label>33.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Saudemont</surname><given-names>B.</given-names></string-name>, <string-name><surname>Popa</surname><given-names>A.</given-names></string-name>, <string-name><surname>Parmley</surname><given-names>J.L.</given-names></string-name>, <string-name><surname>Rocher</surname><given-names>V.</given-names></string-name>, <string-name><surname>Blugeon</surname><given-names>C.</given-names></string-name>, <string-name><surname>Necsulea</surname><given-names>A.</given-names></string-name>, <string-name><surname>Meyer</surname><given-names>E.</given-names></string-name>, <string-name><surname>Duret</surname><given-names>L.</given-names></string-name></person-group><article-title>The fitness cost of mis-splicing is the main determinant of alternative splicing patterns</article-title>. <source>Genome Biol.</source><year>2017</year>; <volume>18</volume>:<fpage>208</fpage>.<pub-id pub-id-type="pmid">29084568</pub-id></mixed-citation>
    </ref>
    <ref id="B34">
      <label>34.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Morales</surname><given-names>J.</given-names></string-name>, <string-name><surname>Pujar</surname><given-names>S.</given-names></string-name>, <string-name><surname>Loveland</surname><given-names>J.E.</given-names></string-name>, <string-name><surname>Astashyn</surname><given-names>A.</given-names></string-name>, <string-name><surname>Bennett</surname><given-names>R.</given-names></string-name>, <string-name><surname>Berry</surname><given-names>A.</given-names></string-name>, <string-name><surname>Cox</surname><given-names>E.</given-names></string-name>, <string-name><surname>Davidson</surname><given-names>C.</given-names></string-name>, <string-name><surname>Ermolaeva</surname><given-names>O.</given-names></string-name>, <string-name><surname>Farrell</surname><given-names>C.M.</given-names></string-name><etal>et al</etal>.</person-group><article-title>A joint NCBI and EMBL-EBI transcript set for clinical genomics and research</article-title>. <source>Nature</source>. <year>2022</year>; <volume>604</volume>:<fpage>310</fpage>–<lpage>315</lpage>.<pub-id pub-id-type="pmid">35388217</pub-id></mixed-citation>
    </ref>
    <ref id="B35">
      <label>35.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gustavsson</surname><given-names>E.K.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>D.</given-names></string-name>, <string-name><surname>Reynolds</surname><given-names>R.H.</given-names></string-name>, <string-name><surname>Garcia-Ruiz</surname><given-names>S.</given-names></string-name>, <string-name><surname>Ryten</surname><given-names>M.</given-names></string-name></person-group><article-title>ggtranscript: an r package for the visualization and interpretation of transcript isoforms using ggplot2</article-title>. <source>Bioinformatics</source>. <year>2022</year>; <volume>38</volume>:<fpage>3844</fpage>–<lpage>3846</lpage>.<pub-id pub-id-type="pmid">35751589</pub-id></mixed-citation>
    </ref>
    <ref id="B36">
      <label>36.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sauvageau</surname><given-names>M.</given-names></string-name>, <string-name><surname>Goff</surname><given-names>L.A.</given-names></string-name>, <string-name><surname>Lodato</surname><given-names>S.</given-names></string-name>, <string-name><surname>Bonev</surname><given-names>B.</given-names></string-name>, <string-name><surname>Groff</surname><given-names>A.F.</given-names></string-name>, <string-name><surname>Gerhardinger</surname><given-names>C.</given-names></string-name>, <string-name><surname>Sanchez-Gomez</surname><given-names>D.B.</given-names></string-name>, <string-name><surname>Hacisuleyman</surname><given-names>E.</given-names></string-name>, <string-name><surname>Li</surname><given-names>E.</given-names></string-name>, <string-name><surname>Spence</surname><given-names>M.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Multiple knockout mouse models reveal lincRNAs are required for life and brain development</article-title>. <source>Elife</source>. <year>2013</year>; <volume>2</volume>:<fpage>e01749</fpage>.<pub-id pub-id-type="pmid">24381249</pub-id></mixed-citation>
    </ref>
    <ref id="B37">
      <label>37.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zheng</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Yu</surname><given-names>X.</given-names></string-name>, <string-name><surname>He</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Guo</surname><given-names>W.</given-names></string-name></person-group><article-title>FENDRR: a pivotal, cancer-related, long non-coding RNA</article-title>. <source>Biomed. Pharmacother.</source><year>2021</year>; <volume>137</volume>:<fpage>111390</fpage>.<pub-id pub-id-type="pmid">33761608</pub-id></mixed-citation>
    </ref>
    <ref id="B38">
      <label>38.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Landrum</surname><given-names>M.J.</given-names></string-name>, <string-name><surname>Lee</surname><given-names>J.M.</given-names></string-name>, <string-name><surname>Riley</surname><given-names>G.R.</given-names></string-name>, <string-name><surname>Jang</surname><given-names>W.</given-names></string-name>, <string-name><surname>Rubinstein</surname><given-names>W.S.</given-names></string-name>, <string-name><surname>Church</surname><given-names>D.M.</given-names></string-name>, <string-name><surname>Maglott</surname><given-names>D.R.</given-names></string-name></person-group><article-title>ClinVar: public archive of relationships among sequence variation and human phenotype</article-title>. <source>Nucleic Acids Res.</source><year>2014</year>; <volume>42</volume>:<fpage>D980</fpage>–<lpage>D985</lpage>.<pub-id pub-id-type="pmid">24234437</pub-id></mixed-citation>
    </ref>
    <ref id="B39">
      <label>39.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Collado-Torres</surname><given-names>L.</given-names></string-name>, <string-name><surname>Burke</surname><given-names>E.E.</given-names></string-name>, <string-name><surname>Peterson</surname><given-names>A.</given-names></string-name>, <string-name><surname>Shin</surname><given-names>J.</given-names></string-name>, <string-name><surname>Straub</surname><given-names>R.E.</given-names></string-name>, <string-name><surname>Rajpurohit</surname><given-names>A.</given-names></string-name>, <string-name><surname>Semick</surname><given-names>S.A.</given-names></string-name>, <string-name><surname>Ulrich</surname><given-names>W.S.</given-names></string-name><collab>BrainSeq Consortium BrainSeq Consortium</collab><string-name><surname>Price</surname><given-names>A.J.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Regional heterogeneity in gene expression, regulation, and coherence in the frontal cortex and hippocampus across development and schizophrenia</article-title>. <source>Neuron</source>. <year>2019</year>; <volume>103</volume>:<fpage>203</fpage>–<lpage>216</lpage>.<pub-id pub-id-type="pmid">31174959</pub-id></mixed-citation>
    </ref>
    <ref id="B40">
      <label>40.</label>
      <mixed-citation publication-type="journal"><collab>BrainSeq Consortium</collab><article-title>Brainseq: neurogenomics to drive novel target discovery for neuropsychiatric disorders</article-title>. <source>Neuron</source>. <year>2015</year>; <volume>88</volume>:<fpage>1078</fpage>–<lpage>1083</lpage>.<pub-id pub-id-type="pmid">26687217</pub-id></mixed-citation>
    </ref>
    <ref id="B41">
      <label>41.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Birnbaum</surname><given-names>R.</given-names></string-name>, <string-name><surname>Jaffe</surname><given-names>A.E.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Shin</surname><given-names>J.H.</given-names></string-name><collab>BrainSeq Consortium BrainSeq Consortium</collab><string-name><surname>Kleinman</surname><given-names>J.E.</given-names></string-name>, <string-name><surname>Hyde</surname><given-names>T.M.</given-names></string-name>, <string-name><surname>Weinberger</surname><given-names>D.R</given-names></string-name></person-group><article-title>Investigating the neuroimmunogenic architecture of schizophrenia</article-title>. <source>Mol. Psychiatry</source>. <year>2018</year>; <volume>23</volume>:<fpage>1251</fpage>–<lpage>1260</lpage>.<pub-id pub-id-type="pmid">28485405</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
